EP3474841
Aðferðir til meðhöndlunar á AR+ brjóstakrabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.6.2017EP published:
16.3.2022EP application number:
17816081.8
EP translation filed:
28.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
19.6.2037Expiry date:
19.6.2026Next due date:
30.6.2026
Title in English:
AR+ BREAST CANCER TREATMENT METHODSLanguage of the patent:
English
Timeline
Today
20.6.2017EP application
16.3.2022EP Publication
28.4.2022Translation submitted
15.6.2022Registration published
19.6.2026Expires
Owner
Name:
Ellipses Pharma LtdAddress:
10 Stratton Street, London, W1J 8LG, GB
Inventor
Name:
HATTERSLEY, GaryAddress:
Stow MA 01775, US
Name:
SAEH, JamalAddress:
Belmont MA 02478, US
Name:
YU, ZiyangAddress:
Wellesley MA 02481, US
Name:
MILLER, ChrisAddress:
Lake Forest IL 60045, US
Name:
BIHANI, TeeruAddress:
Cambridge MA 02140, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662353350 PDate:
22.6.2016Country:
US
Number:
201662377497 PDate:
19.8.2016Country:
US
Number:
201762461546 PDate:
21.2.2017Country:
US
Classification
Categories:
A61K 31/277, C07D 413/10, C07D 413/12, A61K 31/138, A61K 31/4245, A61K 31/436, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.5.2022
Expires: 19.6.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.5.2023
Expires: 19.6.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.5.2024
Expires: 19.6.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 30.6.2025
Expires: 19.6.2026
Payer: Árnason Faktor ehf.